Showing results (41-50 of 100) with videos related to
Sort By:
Pageof 10
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 29, 2016
Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal CarcinomaV Lee, Sum-Yin Chan, Cheuk-Wai Choi, et al.Journal of the National Cancer Center|July 22, 2024
Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancerHao Yu, Ka-On Lam, Michael D Green, et al.Cancers|April 30, 2021
Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCCYawen Dong, Jeffrey Sum Lung Wong, Ryohichi Sugimura, et al.Radiology. Artificial Intelligence|May 3, 2021
Radiomics Model to Predict Early Progression of Nonmetastatic Nasopharyngeal Carcinoma after Intensity Modulation Radiation Therapy: A Multicenter StudyRichard Du, Victor H Lee, Hui Yuan, et al.Frontiers in Oncology|November 17, 2022
A meta-analysis with systematic review: Efficacy and safety of immune checkpoint inhibitors in patients with advanced gastric cancerAya El Helali, Jun Tao, Charlene H L Wong, et al.The Oncologist|June 17, 2024
Association of sarcopenia with severe chemotherapy toxicities and survival in patients with advanced gastric cancerWing-Lok Chan, Ho-Kwan Bryan Yun, Emina Edith Cheung, et al.Plos One|June 25, 2016
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal CarcinomaVictor H F Lee, Anthony W I Lo, Chun-Yin Leung, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 17, 2020
Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinomaYihuai Hu, Chenyi Xie, Hong Yang, et al.Hepatology Communications|July 27, 2022
Inhibition of lysyl oxidase-like 2 overcomes adhesion-dependent drug resistance in the collagen-enriched liver cancer microenvironmentLanqi Gong, Yu Zhang, Yuma Yang, et al.Cancers|January 23, 2024
Shift in Tissue-Specific Immune Niches and CD137 Expression in Tuberculoma of Pembrolizumab-Treated Nasopharyngeal Carcinoma PatientsNgar Woon Kam, Anthony Wing Ip Lo, Desmond Tae Yang Hung, et al.Pageof 10